Breakthrough Fellowship Program – R&D Finance
This program is designed to enhance our pipeline of diverse talent of leaders. The Breakthrough Fellowship Program, first-of-its-kind, works to advance students and early career colleagues of Black/African American, Latino/Hispanic and Native American descent with a goal of developing 100 fellows by 2025. One of Pfizer’s Bold Moves is to create a workplace for all, and we are committed to increasing diversity by fostering a more inclusive workplace. Every Pfizer ‘Breakthrough’ program is designed to cultivate a pipeline of diverse talent. Everything we do is driven by our purpose.
Applicants for the Breakthrough Fellowship Program 10-week internship and intend to pursue their Master of Business Administration degree (MBA), or Master of Public Health (MPH) degree consistent with the time requirements of the program.
Breakthrough Fellow – R&D Finance - This opportunity will support the Research & Development (R&D) Finance organizations supporting the Global Product Development (GPD) and Worldwide Research & Development and Medical (WRDM) organizations which represent Pfizer’s R&D activities from early discovery, through commercialization.
- Current Junior in a 4-year Bachelor’s degree in Accounting or Finance related coursework with a graduation date of Dec ‘22 or Spring 2023.
- Ideally in a discipline with exposure and experience with accounting or finance
- Strong analytical skills, with experience in cost or financial analysis
- Proficient in Microsoft Office applications (Excel, Word, and PowerPoint)
- Min GPA 3.0
- Applicants must be immediately authorized to work in the U.S. Work visa sponsorship not available for this opportunity.
Location - New York City, Groton CT, Cambridge MA, Collegeville PA or virtual remote should the 2022 summer session need be.
Applicants must be immediately authorized to work in the U.S. Work visa sponsorship not available for this opportunity. Pfizer is an equal opportunity and E-Verify employer.
Other Job Details:
- Last Date to Apply for Job: February 10, 2022
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.